Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host-microbiota ecosystem and intestinal epithelial barrier constitute a dynamic interface that separates the internal environment from the external luminal contents. This system includes a physical barrier of epithelial cells joined by tight junctions, a chemical barrier of mucus and antimicrobial peptides, and a diverse microbial community that interacts with the host immune system (Vancamelbeke & Vermeire, 2017). The microbiota plays a crucial role in fermenting dietary fibers into short-chain fatty acids, which serve as energy for colonocytes and maintain barrier integrity (Thursby & Juge, 2017). Disruptions to this ecosystem, known as dysbiosis, can lead to increased intestinal permeability, allowing the translocation of pro-inflammatory molecules like lipopolysaccharides into the bloodstream (Chelakkot et al., 2018). This "leaky gut" state is associated with various conditions, including inflammatory bowel disease, metabolic syndrome, and certain autoimmune disorders. Therapeutic interventions focus on restoring this balance through probiotics, prebiotics, or fecal microbiota transplantation to reinforce the barrier and modulate the host's immune response. Additionally, pharmacological agents like mucosal protectants and specific antibiotics are used to manage the microbial environment and protect the epithelial lining. Understanding the cross-talk between host cells and the microbiome is essential for developing targeted therapies for chronic inflammatory and metabolic diseases.
Modulation of microbial composition, enhancement of tight junction protein expression, and regulation of mucosal immune cell activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host-microbiota ecosystem and intestinal epithelial barrier.